Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential

Journal of Assisted Reproduction and Genetics

Volumn 17, Issue 1, 2000, Pages 20-27

  Balasch, Juan ^a,b   Fábregues, Francisco ^a   Creus, Montserrat ^a   Peñarrubia, Joana ^a   Vidal, Esther ^a   Carmona, Francisco ^a   Puerto, Bienvenido ^a   Vanrell, Juan A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Induction of ovulation; IVF; Oocyte maturity; Recombinant FSH; Urinary FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; NIDATION; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION INDUCTION; PRIORITY JOURNAL;

ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; LEUPROLIDE; OVARIAN FOLLICLE; OVULATION; OVULATION INDUCTION; PITUITARY GLAND; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS;

EID: 0343963296     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009493829086     Document Type: Article

References (28)

1. Simoni M, Nieschlag E: FSH in therapy: Physiological basis, new preparations and clinical use. Reprod Med Rev 1995;4:163-177
2. Lunenfeld B, Lunenfeld E: Gonadotropic preparations-lessons learned. Fertil Steril 1997;67:812-814
3. Howles CM: Genetic engineering of human FSH (Gonal-F). Hum Reprod Update 1996;2:172-191.
4. Olijve W, de Boer W, Mulders JWM, van Wezenbeek PMGF: Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996;2:371-382
5. Daya S: hMG versus FSH: is there any difference? In Ovulation Induction - Update '98, M Filicori, C Flamigni (eds). New York, Parthenon, 1998, pp.183-192
6. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT: A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-2540
7. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
8. Balasch J, Miró F, Burzaco I, Casamitjana R, Civico S, Ballescá JL, Puerto B, Vanrell JA: The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-1683
9. Balasch J, Fábregues F, Peñarrubia J, Creus M, Vidal R, Casamitjana R, Manau D, Vanrell JA: Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone adminstration in ovulatory women and WHO group II anovulatory infertile patients. J Assist Reprod Genet 1998;15:552-559
10. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G: Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552-556
11. Shoham Z, Balen A, Patel A, Jacobs HS: Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991;56:1048-1053
12. Out HJ, Driessen SGAJ, Mannaerts BMJL, Coelingh Bennink HJT: Recombinant follicle-stimulating hormone (follitropin beta, Puregon*) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997;68:138-142
13. Gregory L: Ovarian markers of implantation potential in assisted reproduction. Hum Reprod 1998;13 (Suppl. 4):117-132
14. Fábregues F, Balasch J, Creus M, Cívico S, Carmona F, Puerto B, Vanrell JA: Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertil Steril 1998;70:46-51
15. Veeck LL: Atlas of the Human Oocyte and Early Conceptus. Baltimore, Williams & Wilkins, 1986
16. Rodgers M, McLoughlin J, Peers N, Anderson J, Woods P, Mitchell GG, Robertson WR: Accumulation of human chorionic gonadotrophin in the serum of patients during in-vitro fertilization treatment cycles with Pergonal. Hum Reprod 1994;9:638-642
17. Hull MGR, Armatage RJ, McDermott A: Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 1994;62:997-1003
18. Balasch J, Fábregues F, Creus M, Moreno V, Puerto B, Peñarrubia J, Carmona F, Vanrell JA: Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum Reprod 1996;11:2400-2404
19. Hedon B, Out HJ, Hugues JN, Camier B, Cohen J, Lopes P, Zorn JR, van der Heijden B, Coelingh Bennink HJT: Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: A prospective, randomized, assessor-blind, multicentre trial. Hum Reprod 1995;10:3102-3106
20. Frydman R, Avril C, Camier B, Carles F, Cornet D, Moreau L, Ragage JP, Sage JC, Thebault A, Howles CM, Truong F: A double-blind, randomized study comparing the efficacy of recombinant human follicle stimulating hormone (rhFSH-Gonal F) and highly purified urinary FSH (uhFSH/Metrodin HP) in inducing superovulation in women undergoing assisted reproductive techniques. 14th Annual Meeting of the European Society for Human Reproduction and Embriology, Goteborg. Hum Reprod 1998;13 (Abstract Book 1):94
21. Rojas FJ: Effects of ovulation induction with gonadotrophins on the ovary and uterus and their implications for assisted reproduction. Hum Reprod 1995;10:2219-2224
22. Hillier SG: Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-191
23. Lolis DE, Tsolas O, Messinis IE: The follicle-stimulating hormone threshold level for follicle maturation in superovulated cycles. Fertil Steril 1995;63:1272-1277
24. Porchet HC, Le Cotonnec JY, Loumaye E: Clinical pharmacology studies of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration. Fertil Steril 1994;61:687-695
25. Ben-Rafael Z, Levy T, Schoemaker J: Pharmacokinetics of follicle stimulating hormone: clinical significance. Fertil Steril 1995;63:689-700
26. van Santbrink EJP, Hop WC, van Dessel TJHM, de Jong FH, Fauser BCJM: Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 1995;64:37-43
27. van Os HC, Alberda AT, Janssen-Caspers HAB, Leerentveld RA, Scholtes MCW, Zeilmaker GH: The influence of the interval between in vitro fertilization and embryo transfer and some other variables on treatment outcome. Fertil Steril 1989;51:360-362
28. Huisman GJ, Alberda AT, Leerentveld RA, Verhoeff A, Zeilmaker GH: A comparison of in vitro fertilization results after embryo transfer after 2, 3, and 4 days of embryo culture. Fertil Steril 1994;61:970-971